What just happened
The Justice Department issued a Final Order immediately placing two categories of marijuana in Schedule III of the Controlled Substances Act: FDA‑approved drug products containing marijuana and marijuana products regulated by a qualifying state medical marijuana license. DOJ also launched an expedited hearing, set to begin June 29, 2026, to evaluate broader rescheduling for adult‑use cannabis. Several summaries of the order note an effective date of April 22, 2026 for the medical categories. Adult‑use cannabis and unlicensed bulk marijuana remain in Schedule I.
Why Treasury and IRS are stepping in
Following the DOJ order, Treasury said it will issue tax guidance to address the “principal federal tax issues stemming from the Final Order.” Treasury and IRS signaled that DOJ’s action should have “significant positive tax consequences” for medical marijuana businesses by addressing how Internal Revenue Code Section 280E applies after rescheduling. Critically, forthcoming guidance is expected to include a transition rule: for 280E purposes, rescheduling generally would first apply to the business’s full taxable year that includes the Final Order’s effective date, for activities that no longer involve Schedule I or II substances.
What this means for trucking employers
Despite the federal rescheduling for certain medical products, nothing changes for DOT‑regulated drug and alcohol testing. Under 49 CFR Part 40, marijuana remains a prohibited substance for safety‑sensitive transportation workers, including CDL drivers. MROs cannot accept medical marijuana prescriptions as a valid explanation for a positive THC test, and employers must continue to follow all Clearinghouse requirements. In short: CDL drivers still cannot use marijuana—on or off duty—regardless of state law.
- Driver use remains prohibited: Keep your zero‑tolerance policy intact and remind drivers that DOT drug rules are unchanged by the DOJ order.
- Avoid confusion in the field: Expect questions as headlines spread. Re‑train supervisors on reasonable‑suspicion procedures and reiterate that a state medical card does not protect a CDL holder under federal testing rules.
- Watch client operations, not just headlines: If you provide intrastate logistics, warehousing, or specialized courier services to state‑licensed medical operators, confirm that your customers are aligning with DEA registration and other federal requirements created by the new Schedule III framework. The DOJ order’s scope is narrow and does not cover adult‑use operators.
The tax angle: downstream effects you might feel
Most carriers won’t experience a direct federal tax change from DOJ’s action. However, state‑licensed medical marijuana customers could see meaningful relief as 280E no longer disallows ordinary and necessary business deductions for activities covered by the Final Order. Stronger after‑tax cash flow for those shippers could improve payment reliability and support volumes for vendors and service partners, including regional haulers and secure couriers. Treasury’s expected transition rule—tying 280E relief to the taxable year that includes the Final Order’s effective date—will matter for contract pricing, budgeting, and credit decisions with those accounts. Keep in mind that adult‑use operators remain outside the order’s scope and still face 280E until further federal action.
Action checklist for fleet managers and owner‑operators
- Reaffirm policy: Send a short compliance memo to drivers and dispatch clarifying that DOT drug rules are unchanged and marijuana remains prohibited for CDL holders. Include a refresher on Clearinghouse obligations.
- Map exposure: Identify any customers tied to state‑licensed medical cannabis supply chains. Ask how they are approaching DEA registration and compliance under the new Schedule III framework.
- Plan for tax timing: If you operate subsidiaries or affiliates that serve medical operators, flag Treasury’s forthcoming 280E guidance and the expected “taxable year including the effective date” transition rule for your CPA. Build scenarios for receivables, rates, and credit limits as customers’ tax positions improve.
- Monitor further changes: DOJ’s separate hearing on broader rescheduling begins June 29, 2026. Any expansion to adult‑use would have larger market impacts—but DOT testing rules for drivers would still govern safety‑sensitive work unless and until DOT revises Part 40.
Bottom line: The DOJ’s medical marijuana rescheduling is a narrow but consequential policy shift on taxes for state‑licensed medical operators. For trucking, safety and compliance fundamentals do not change, but some customers’ balance sheets might. Stay focused on DOT compliance while tracking Treasury’s guidance for potential knock‑on effects in your customer base.
Sources Consulted: U.S. Department of the Treasury; U.S. Department of Justice; U.S. Department of Transportation, Office of Drug & Alcohol Policy & Compliance; Foley & Lardner LLP analysis; Commercial Carrier Journal.
Need to file your Form 2290?
Join thousands of owner-operators and carriers who trust HeavyTax.com for fast and easy HVUT e-filing.
This article was prepared exclusively for truckstopinsider.com. For professional tax advice, consult a qualified professional.
